No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Lialda is a medication used to treat ulcerative colitis, a type of inflammatory bowel disease. It is a mesalamine drug, which works by reducing inflammation in the digestive tract. It is taken orally, usually in the form of a tablet or capsule. It is also available as an enema or suppository. Lialda is used to treat mild to moderate ulcerative colitis and can help reduce symptoms such as abdominal pain, diarrhea, and rectal bleeding. It can also help prevent flare-ups of the disease.
The Lialda market is a subset of the larger Gastrointestinal Drugs market. This market includes a variety of medications used to treat digestive disorders, such as irritable bowel syndrome, Crohn's disease, and ulcerative colitis. These medications are used to reduce inflammation, relieve pain, and improve digestion.
Some companies in the Lialda market include Shire Pharmaceuticals, Allergan, and AbbVie. These companies produce and distribute Lialda and other medications used to treat gastrointestinal disorders. Show Less Read more
